Blood Pressure Medication for Chronic Pain
(PASSION Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore the effects of a common blood pressure medication, Hydrochlorothiazide, on chronic pain levels. Participants will take the medication for two weeks and a placebo (a pill with no active ingredients) for another two weeks. The trial targets individuals with chronic low back pain and a spinal cord stimulator implant, who also have high blood pressure. Participants must be willing to visit a research lab and undergo a blood draw. As an Early Phase 1 trial, this research seeks to understand how the treatment works in people, offering participants a chance to contribute to groundbreaking insights.
Will I have to stop taking my current medications?
If you are currently taking any blood pressure medication, you cannot participate in this trial. If you are taking NSAIDs (non-steroidal anti-inflammatory drugs), you must stop them for at least 3 days before and during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that hydrochlorothiazide, a common medication for high blood pressure, is usually well-tolerated when taken as directed. It has been used for a long time and is often prescribed to manage high blood pressure. However, like any medication, it can cause side effects. Some people might feel dizzy, especially when they first start taking it. Serious side effects are rare but can include skin reactions or joint pain.
In this trial, participants take a 12.5 mg dose of hydrochlorothiazide twice a day. This lower dose may help reduce the chances of side effects. Since this is an early-phase study, the main goal is to monitor any side effects and assess how the treatment affects chronic pain.12345Why are researchers excited about this trial?
Researchers are excited about using hydrochlorothiazide, a blood pressure medication, for chronic pain because it offers a fresh approach by potentially addressing pain through blood pressure regulation. Unlike traditional pain relievers like opioids, which can have addictive properties, hydrochlorothiazide is a diuretic that reduces fluid retention and lowers blood pressure, which might indirectly alleviate pain. This repurposing of a common hypertension drug could lead to fewer side effects and offer a safer alternative for managing chronic pain.
What evidence suggests that this treatment might be an effective treatment for chronic pain?
Research has shown that hydrochlorothiazide, a common medication for high blood pressure, might also aid in pain relief. One study examined its ability to ease ongoing stomach pain, suggesting it could help with pain beyond just lowering blood pressure. In this trial, some participants will receive hydrochlorothiazide to explore its potential for pain reduction. Hydrochlorothiazide helps the body remove extra water, which lowers blood pressure. While primarily used for high blood pressure, its potential to reduce pain remains under investigation. There is no clear consensus yet on using hydrochlorothiazide specifically for long-term pain, but its effects on pain continue to be researched.26789
Who Is on the Research Team?
Seth W Holwerda, PhD
Principal Investigator
University of Kansas Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 40-79 with chronic low back pain and high blood pressure (BP 130-139/80-89 mmHg or higher), who have a spinal cord stimulator implant. Participants should not be on blood pressure medication, pregnant, or have conditions like diabetes requiring insulin, active infections, renal failure, history of stroke or certain neurological diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 2 weeks of a diuretic and 2 weeks of placebo in a crossover design to assess the impact on pain management and blood pressure
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of pain and blood pressure
What Are the Treatments Tested in This Trial?
Interventions
- Hydrochlorothiazide 12.5mg
- Placebo
- Spinal Cord Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor